Skip to content

The 'Livassured' Combined Sensor system to detect Epileptic Noctural SEizures (LICSENSE)

The 'Livassured' Combined Sensor system to detect Epileptic Noctural SEizures (LICSENSE) - LICSENSE trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44973
Enrollment
51
Registered
2014-09-01
Start date
2015-01-13
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

None listed

Sponsors

Epilepsiecentrum Kempenhaeghe
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Subjects who meet all of the following criteria are eligible for this trial: 1. Between 2 and 18 years of age with or without mental impairment, or between 18 - 65 years with a mental impairment. 2. Major motor seizures defined as tonic-clonic, generalized tonic, hypermotor or series of myoclonic seizures. 3. Minimal nocturnal seizure frequency: 1/month. 4. The mentally impaired patients all live in the long-term facilities at Kempenhaeghe or SEIN. Children may live in their family home. 5. Informed consent form signed by legal representatives.

Exclusion criteria

Exclusion criteria: Subjects meeting one or more of the following criteria cannot be selected: 1. Intensive non-epileptic movement patterns such as severe choreatiform movements due to birth defects, intensive sleep walking, frequent night terrors (> 1/night) 2. Only minor motor seizures: non-generalised or short (

Design outcomes

Primary

MeasureTime frame
The combined analysis of heart rate and accelerometry, the added value of video/audio analysis and the technical performance are primary endpoints.

Secondary

MeasureTime frame
Secondary end points are the performances of heart rate, accelerometry, video and audio alone, comparison with the Emfit bed sensor, quality of life, optimalisation of care and levels of trust of caregivers in system performance.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)